SUMO‐modified insulin‐like growth factor 1 receptor (IGF‐1R) increases cell cycle progression and cell proliferation

Increasing number of studies have shown nuclear localization of the insulin‐like growth factor 1 receptor (nIGF‐1R) in tumor cells and its links to adverse clinical outcome in various cancers. Any obvious cell physiological roles of nIGF‐1R have, however, still not been disclosed. Previously, we rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yingbo, Liu, Hongyu, Waraky, Ahmed, Haglund, Felix, Agarwal, Prasoon, Jernberg‐Wiklund, Helena, Warsito, Dudi, Larsson, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518303/
https://www.ncbi.nlm.nih.gov/pubmed/28112398
http://dx.doi.org/10.1002/jcp.25818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518303/
https://www.ncbi.nlm.nih.gov/pubmed/28112398
http://dx.doi.org/10.1002/jcp.25818

Ejemplares similares